Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000031.xml
Klin Monbl Augenheilkd 2022; 239(09): 1119-1124
DOI: 10.1055/a-1830-3277
DOI: 10.1055/a-1830-3277
Übersicht
Vitreoretinal Surgery in Glaucoma
Article in several languages: deutsch | English
Abstract
Glaucoma is associated with the demise of retinal ganglion cells and their axons, primarily located in the retina. Vitreoretinal and glaucoma surgery overlap to a not inconsiderable extent in certain diseases. This overview article aims to present these diseases and highlight treatment strategies and the respective modes of action collectively. This article describes malignant glaucoma or aqueous misdirection syndrome, retinal surgery for choroidal detachment and expulsive choroidal hemorrhage, postoperative blebitis and endophthalmitis after glaucoma surgery, and vitrectomy after glaucoma surgery, along with the therapeutic paths for managing complications. The areas of glaucoma and vitreoretinal surgery are tightly linked. Colleagues from both subspecialties should be familiar with a certain overview of diseases concerning both subject areas.
Publication History
Received: 28 February 2022
Accepted: 19 April 2022
Accepted Manuscript online:
20 April 2022
Article published online:
04 August 2022
© 2022. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References/Literatur
- 1 Byrnes GA, Leen MM, Wong TP. et al. Vitrectomy for ciliary block (malignant) glaucoma. Ophthalmology 1995; 102: 1308-1311 DOI: 10.1016/s0161-6420(95)30870-6.
- 2 Trope GE, Pavlin CJ, Bau A. et al. Malignant glaucoma. Clinical and ultrasound biomicroscopic features. Ophthalmology 1994; 101: 1030-1035 DOI: 10.1016/s0161-6420(94)31222-x.
- 3 von Graefe A. Beiträge zur Pathologie und Therapie des Glaucoms. Archiv für Ophthalmologie 1869; 15: 108-252
- 4 Harbour JW, Rubsamen PE, Palmberg P. Pars plana vitrectomy in the management of phakic and pseudophakic malignant glaucoma. Arch Ophthalmol 1996; 114: 1073-1078 DOI: 10.1001/archopht.1996.01100140275003.
- 5 Little BC, Hitchings RA. Pseudophakic malignant glaucoma: Nd : YAG capsulotomy as a primary treatment. Eye (Lond) 1993; 7: 102-104 DOI: 10.1038/eye.1993.21.
- 6 Tsai JC, Barton KA, Miller MH. et al. Surgical results in malignant glaucoma refractory to medical or laser therapy. Eye (Lond) 1997; 11: 677-681 DOI: 10.1038/eye.1997.176.
- 7 Cashwell LF, Martin TJ. Malignant glaucoma after laser iridotomy. Ophthalmology 1992; 99: 651-658 discussion 658–659 DOI: 10.1016/s0161-6420(92)31913-x.
- 8 Mastropasqua L, Ciancaglini M, Carpineto P. et al. Aqueous misdirection syndrome: a complication of neodymium: YAG posterior capsulotomy. J Cataract Refract Surg 1994; 20: 563-565 DOI: 10.1016/s0886-3350(13)80238-6.
- 9 Hardten DR, Brown JD. Malignant glaucoma after Nd : YAG cyclophotocoagulation. Am J Ophthalmol 1991; 111: 245-247 DOI: 10.1016/s0002-9394(14)72271-8.
- 10 Chandler PA, Simmons RJ, Grant WM. Malignant glaucoma. Medical and surgical treatment. Am J Ophthalmol 1968; 66: 495-502
- 11 Simmons RJ. Malignant glaucoma. Br J Ophthalmol 1972; 56: 263-272 DOI: 10.1136/bjo.56.3.263.
- 12 Lau OC, Montfort JM, Sim BW. et al. Acute intraoperative rock-hard eye syndrome and its management. J Cataract Refract Surg 2014; 40: 799-804 DOI: 10.1016/j.jcrs.2013.10.038.
- 13 Ruben S, Tsai J, Hitchings RA. Malignant glaucoma and its management. Br J Ophthalmol 1997; 81: 163-167 DOI: 10.1136/bjo.81.2.163.
- 14 Greenfield DS, Tello C, Budenz DL. et al. Aqueous misdirection after glaucoma drainage device implantation. Ophthalmology 1999; 106: 1035-1040 DOI: 10.1016/S0161-6420(99)00530-8.
- 15 Luntz MH, Rosenblatt M. Malignant glaucoma. Surv Ophthalmol 1987; 32: 73-93 DOI: 10.1016/0039-6257(87)90101-9.
- 16 Foreman-Larkin J, Netland PA, Salim S. Clinical Management of Malignant Glaucoma. J Ophthalmol 2015; 2015: 283707 DOI: 10.1155/2015/283707.
- 17 Sharma A, Sii F, Shah P. et al. Vitrectomy-phacoemulsification-vitrectomy for the management of aqueous misdirection syndromes in phakic eyes. Ophthalmology 2006; 113: 1968-1973 DOI: 10.1016/j.ophtha.2006.04.031.
- 18 Dave P, Senthil S, Rao HL. et al. Treatment outcomes in malignant glaucoma. Ophthalmology 2013; 120: 984-990 DOI: 10.1016/j.ophtha.2012.10.024.
- 19 Krix-Jachym K, Zarnowski T, Rekas M. Risk Factors of Malignant Glaucoma Occurrence after Glaucoma Surgery. J Ophthalmol 2017; 2017: 9616738 DOI: 10.1155/2017/9616738.
- 20 Sahoo NK, Balijepalli P, Singh SR. et al. Retina and glaucoma: surgical complications. Int J Retina Vitreous 2018; 4: 29 DOI: 10.1186/s40942-018-0135-x.
- 21 Gedde SJ, Herndon LW, Brandt JD. et al. Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol 2012; 153: 804-814.e1 DOI: 10.1016/j.ajo.2011.10.024.
- 22 Investigators A. The Advanced Glaucoma Intervention Study (AGIS): 11. Risk factors for failure of trabeculectomy and argon laser trabeculoplasty. Am J Ophthalmol 2002; 134: 481-498 DOI: 10.1016/s0002-9394(02)01658-6.
- 23 Jampel HD, Musch DC, Gillespie BW. et al. Perioperative complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS). Am J Ophthalmol 2005; 140: 16-22 DOI: 10.1016/j.ajo.2005.02.013.
- 24 Budenz DL, Barton K, Feuer WJ. et al. Treatment outcomes in the Ahmed Baerveldt Comparison Study after 1 year of follow-up. Ophthalmology 2011; 118: 443-452 DOI: 10.1016/j.ophtha.2010.07.016.
- 25 Reitsamer H, Sng C, Vera V. et al. Two-year results of a multicenter study of the ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 2019; 257: 983-996 DOI: 10.1007/s00417-019-04251-z.
- 26 Theilig T, Rehak M, Busch C. et al. Comparing the efficacy of trabeculectomy and XEN gel microstent implantation for the treatment of primary open-angle glaucoma: a retrospective monocentric comparative cohort study. Sci Rep 2020; 10: 19337 DOI: 10.1038/s41598-020-76551-y.
- 27 Verma S, Azad SV, Takkar B. et al. Posterior segment complications following glaucoma surgeries. Indian J Ophthalmol 2020; 68: 988-993 DOI: 10.4103/ijo.IJO_1040_19.
- 28 Jeganathan VS, Ghosh S, Ruddle JB. et al. Risk factors for delayed suprachoroidal haemorrhage following glaucoma surgery. Br J Ophthalmol 2008; 92: 1393-1396 DOI: 10.1136/bjo.2008.141689.
- 29 Learned D, Eliott D. Management of Delayed Suprachoroidal Hemorrhage after Glaucoma Surgery. Semin Ophthalmol 2018; 33: 59-63 DOI: 10.1080/08820538.2017.1353814.
- 30 Laube T, Brockmann C, Bornfeld N. Massive suprachoroidal hemorrhage: Surgical management and outcome. GMS Ophthalmol Cases 2015; 5: Doc10 DOI: 10.3205/oc000032.
- 31 Poulsen EJ, Allingham RR. Characteristics and risk factors of infections after glaucoma filtering surgery. J Glaucoma 2000; 9: 438-443 DOI: 10.1097/00061198-200012000-00004.
- 32 Wallin O, Al-ahramy AM, Lundstrom M. et al. Endophthalmitis and severe blebitis following trabeculectomy. Epidemiology and risk factors; a single-centre retrospective study. Acta Ophthalmol 2014; 92: 426-431 DOI: 10.1111/aos.12257.
- 33 Ang GS, Varga Z, Shaarawy T. Postoperative infection in penetrating versus non-penetrating glaucoma surgery. Br J Ophthalmol 2010; 94: 1571-1576 DOI: 10.1136/bjo.2009.163923.
- 34 Edmunds B, Thompson JR, Salmon JF. et al. The National Survey of Trabeculectomy. III. Early and late complications. Eye (Lond) 2002; 16: 297-303 DOI: 10.1038/sj.eye.6700148.
- 35 Stein JD, Ruiz jr. D, Belsky D. et al. Longitudinal rates of postoperative adverse outcomes after glaucoma surgery among medicare beneficiaries 1994 to 2005. Ophthalmology 2008; 115: 1109-1116.e7 DOI: 10.1016/j.ophtha.2008.03.033.
- 36 Busbee BG, Recchia FM, Kaiser R. et al. Bleb-associated endophthalmitis: clinical characteristics and visual outcomes. Ophthalmology 2004; 111: 1495-1503 discussion 1503 DOI: 10.1016/j.ophtha.2004.01.028.